Literature DB >> 12700374

The epidemiology of sepsis in the United States from 1979 through 2000.

Greg S Martin1, David M Mannino, Stephanie Eaton, Marc Moss.   

Abstract

BACKGROUND: Sepsis represents a substantial health care burden, and there is limited epidemiologic information about the demography of sepsis or about the temporal changes in its incidence and outcome. We investigated the epidemiology of sepsis in the United States, with specific examination of race and sex, causative organisms, the disposition of patients, and the incidence and outcome.
METHODS: We analyzed the occurrence of sepsis from 1979 through 2000 using a nationally representative sample of all nonfederal acute care hospitals in the United States. Data on new cases were obtained from hospital discharge records coded according to the International Classification of Diseases, Ninth Revision, Clinical Modification.
RESULTS: Review of discharge data on approximately 750 million hospitalizations in the United States over the 22-year period identified 10,319,418 cases of sepsis. Sepsis was more common among men than among women (mean annual relative risk, 1.28 [95 percent confidence interval, 1.24 to 1.32]) and among nonwhite persons than among white persons (mean annual relative risk, 1.90 [95 percent confidence interval, 1.81 to 2.00]). Between 1979 and 2000, there was an annualized increase in the incidence of sepsis of 8.7 percent, from about 164,000 cases (82.7 per 100,000 population) to nearly 660,000 cases (240.4 per 100,000 population). The rate of sepsis due to fungal organisms increased by 207 percent, with gram-positive bacteria becoming the predominant pathogens after 1987. The total in-hospital mortality rate fell from 27.8 percent during the period from 1979 through 1984 to 17.9 percent during the period from 1995 through 2000, yet the total number of deaths continued to increase. Mortality was highest among black men. Organ failure contributed cumulatively to mortality, with temporal improvements in survival among patients with fewer than three failing organs. The average length of the hospital stay decreased, and the rate of discharge to nonacute care medical facilities increased.
CONCLUSIONS: The incidence of sepsis and the number of sepsis-related deaths are increasing, although the overall mortality rate among patients with sepsis is declining. There are also disparities among races and between men and women in the incidence of sepsis. Gram-positive bacteria and fungal organisms are increasingly common causes of sepsis. Copyright 2003 Massachusetts Medical Society

Entities:  

Mesh:

Year:  2003        PMID: 12700374     DOI: 10.1056/NEJMoa022139

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  1885 in total

1.  Comparison of the two blood culture systems, Bactec 9240 and BacT/Alert 3D, in the detection of Candida spp. and bacteria with polymicrobial sepsis.

Authors:  L Klingspor; S A Muhammed; V Ozenci
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-06-06       Impact factor: 3.267

Review 2.  Mobilization in severe sepsis: an integrative review.

Authors:  Sushant Govindan; Theodore J Iwashyna; Andrew Odden; Scott A Flanders; Vineet Chopra
Journal:  J Hosp Med       Date:  2015-01       Impact factor: 2.960

3.  Characterization of alpha-toxin hla gene variants, alpha-toxin expression levels, and levels of antibody to alpha-toxin in hemodialysis and postsurgical patients with Staphylococcus aureus bacteremia.

Authors:  Batu K Sharma-Kuinkel; Yuling Wu; David E Tabor; Hoyin Mok; Bret R Sellman; Amy Jenkins; Li Yu; Hasan S Jafri; Thomas H Rude; Felicia Ruffin; Wiley A Schell; Lawrence P Park; Qin Yan; Joshua T Thaden; Julia A Messina; Vance G Fowler; Mark T Esser
Journal:  J Clin Microbiol       Date:  2014-11-12       Impact factor: 5.948

4.  Comparison of the MALDI Biotyper system using Sepsityper specimen processing to routine microbiological methods for identification of bacteria from positive blood culture bottles.

Authors:  Blake W Buchan; Katherine M Riebe; Nathan A Ledeboer
Journal:  J Clin Microbiol       Date:  2011-12-07       Impact factor: 5.948

5.  Dexmedetomidine alleviates LPS-induced septic cardiomyopathy via the cholinergic anti-inflammatory pathway in mice.

Authors:  Weilan Kong; Kai Kang; Yang Gao; Haitao Liu; Xianglin Meng; Songliu Yang; Kaijiang Yu; Mingyan Zhao
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

Review 6.  The inflammatory response in sepsis.

Authors:  Markus Bosmann; Peter A Ward
Journal:  Trends Immunol       Date:  2012-10-02       Impact factor: 16.687

7.  Effects of aging on the immunopathologic response to sepsis.

Authors:  Isaiah R Turnbull; Andrew T Clark; Paul E Stromberg; David J Dixon; Cheryl A Woolsey; Christopher G Davis; Richard S Hotchkiss; Timothy G Buchman; Craig M Coopersmith
Journal:  Crit Care Med       Date:  2009-03       Impact factor: 7.598

8.  Severe sepsis cohorts derived from claims-based strategies appear to be biased toward a more severely ill patient population.

Authors:  Stacey-Ann Whittaker; Mark E Mikkelsen; David F Gaieski; Sherine Koshy; Craig Kean; Barry D Fuchs
Journal:  Crit Care Med       Date:  2013-04       Impact factor: 7.598

9.  Combination therapy with milrinone and esmolol for heart protection in patients with severe sepsis: a prospective, randomized trial.

Authors:  Zenggeng Wang; Qinghua Wu; Xiangbi Nie; Jinghua Guo; Chunli Yang
Journal:  Clin Drug Investig       Date:  2015-11       Impact factor: 2.859

Review 10.  A novel role for coinhibitory receptors/checkpoint proteins in the immunopathology of sepsis.

Authors:  Eleanor A Fallon; Bethany M Biron-Girard; Chun-Shiang Chung; Joanne Lomas-Neira; Daithi S Heffernan; Sean F Monaghan; Alfred Ayala
Journal:  J Leukoc Biol       Date:  2018-02-02       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.